课题基金 / 基金详情

项目摘要

项目成果

Stephen Jay Freedland的其他基金

相似基金

相关文献

中文摘要
翻译
公共卫生声明 前列腺癌是美国男性发病和死亡的主要原因。在这 我们的目标是开发新的无毒补充治疗方法,旨在减缓前列腺癌 进展:饮食调整和植物药物。如果这些临床前研究成功, 这将为未来在前列腺癌患者中进行的临床研究奠定坚实的基础, 从根本上改变和改善对前列腺癌患者的护理的可能性。
英文摘要
PUBLIC HEALTH STATEMENT Prostate cancer is a major cause of morbidity and mortality among men in the United States. In this proposal, we aim to develop novel non-toxic complementary treatments aimed at slowing prostate cancer progression: dietary modification and phytopharmaceuticals. If these pre-clinical studies are successful, this will lay a solid foundation for future clinical studies among men with prostate cancer, which eventually stand the possibility of radically altering and improving care for men with prostate cancer.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1055-9965.epi-14-0236
发表时间: 2014-11
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者: [Allott EH, Howard LE, Song HJ, Sourbeer KN, Koontz BF, Salama JK, Freedland SJ]
通讯作者: Freedland SJ
DOI: 10.1097/cmr.0b013e3283426805
发表时间: 2011-02
期刊: Melanoma research
影响因子: 2.2
作者: [de Ridder GG, Gonzalez-Gronow M, Ray R, Pizzo SV]
通讯作者: Pizzo SV
DOI: 10.1111/bju.12720
发表时间: 2014-11
期刊: BJU international
影响因子: 4.5
作者: [Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ]
通讯作者: Freedland SJ
DOI: 10.1158/1940-6207.capr-10-0071
发表时间: 2010-09-01
期刊: CANCER PREVENTION RESEARCH
影响因子: 3.3
作者: [Masko, Elizabeth M., Thomas, Jean A., II, Freedland, Stephen J.]
通讯作者: Freedland, Stephen J.
13
    A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
    • 批准号:
      10568656
    • 项目类别:
    • 资助金额:
      $73.91万
    • 财政年份:
      2023
    • 负责人:
      Stephen Jay Freedland
    • 依托单位:
    KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
    Racial Differences in Prostate Cancer Molecular Subtyping
    • 批准号:
      10381279
    • 项目类别:
    • 资助金额:
      $8.5万
    • 财政年份:
      2021
    • 负责人:
      Stephen Jay Freedland
    • 依托单位:
    Racial Differences in Prostate Cancer Molecular Subtyping
    • 批准号:
      9889065
    • 项目类别:
    • 资助金额:
      $55.03万
    • 财政年份:
      2018
    • 负责人:
      Stephen Jay Freedland
    • 依托单位:
    海外基金